Search Result

No matches for "

56132

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

By Targets:	Apoptosis (2) Bradykinin Receptor (2) Epigenetic Reader Domain (2) Fluorescent Dye (2) MicroRNA (20) NF-κB (2) p38 MAPK (2) Raf (3) TNF Receptor (2)
By Research Areas:	Cancer (27) Cardiovascular Disease (1) Inflammation/Immunology (2) Metabolic Disease (1) Neurological Disease (3)
Oligonucleotides:	miRNA mimics (5) miRNA antagomirs (5) miRNA agomirs (5) MicroRNAs (20) miRNA inhibitors (5) Antisense Oligonucleotides (5)

Inhibitors & Agonists

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-136175

Revumenib Maximum Cited Publications 15 Publications Verification SNDX-5613	Epigenetic Reader Domain	Cancer
Revumenib (SNDX-5613) is a potent and specific Menin-MLL inhibitor with a binding K_i of 0.149 nM and a cell based IC₅₀ of 10-20 nM. Revumenib can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .

HY-19667A

*BMS-561392* formate** 2 Publications Verification DPC 333 formate	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 formate (DPC 333 formate) is a selective ADAM17(TACE) inhibitor. BMS-561392 formate inhibits TNF-α secretion by regulating signaling pathways such as p44 MAPK and NF-κB. BMS-561392 formate also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 formate promotes microglial apoptosis, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 formate can be used in research related to spinal cord injury and inflammatory diseases .

HY-19667

BMS-561392 DPC 333	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 (BMS-561392) is a selective ADAM17(TACE) inhibitor. BMS-561392 inhibits TNF-α secretion by regulating signaling pathways such as p44 MAPK and NF-κB. BMS-561392 also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 promotes microglial apoptosis, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 can be used in research related to spinal cord injury and inflammatory diseases .

HY-153490

ISIS 5132 CGP 69846A; ISIS 9271	Raf	Cancer
ISIS 5132 is a 20-base phosphorothioate oligonucleotide that specifically down-regulates c-raf expression.

HY-106277A

Fasitibant chloride hydrochloride MEN16132	Bradykinin Receptor	Metabolic Disease
Fasitibant chloride hydrochloride (MEN16132) is a potent, selective, high affinity, and long-lasting nonpeptide bradykinin B₂ (BK₂) receptor antagonist. Fasitibant chloride hydrochloride has proinflammatory effects and can be used for the research of osteoarthritis and rheumatoid arthritis .

HY-153490A

*ISIS 5132* sodium** CGP 69846A sodium; ISIS 9271 sodium	Raf	Cancer
ISIS 5132 sodium is a 20-base phosphorothioate oligonucleotide that specifically down-regulates c-raf expression.

HY-14886

Fasitibant chloride MEN16132 free base	Bradykinin Receptor	Cardiovascular Disease Neurological Disease
Fasitibant chloride (MEN16132 free base) is a potent and selective nonpeptide bradykinin B2 receptor (B2R) antagonist. Fasitibant chloride reduces joint pain and diminishes joint oedema in Carrageenan-induced arthritis rat model .

HY-R01877

*hsa-miR-6132* mimic**	MicroRNA	Cancer
hsa-miR-6132 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-6132 mimic hsa-miR-6132 mimic

HY-R01877A

*hsa-miR-6132* agomir**	MicroRNA	Cancer
hsa-miR-6132 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6132 agomir hsa-miR-6132 agomir

HY-RI01877

*hsa-miR-6132* inhibitor**	MicroRNA	Cancer
hsa-miR-6132 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-6132 inhibitor hsa-miR-6132 inhibitor

HY-R03279

*mmu-miR-5132-5p mimic*	MicroRNA	Cancer
mmu-miR-5132-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5132-5p mimic mmu-miR-5132-5p mimic

HY-RI04508

*rno-miR-5132-3p inhibitor*	MicroRNA	Cancer
rno-miR-5132-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-5132-3p inhibitor rno-miR-5132-3p inhibitor

HY-RI03279

*mmu-miR-5132-5p inhibitor*	MicroRNA	Cancer
mmu-miR-5132-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5132-5p inhibitor mmu-miR-5132-5p inhibitor

HY-R03278

*mmu-miR-5132-3p mimic*	MicroRNA	Cancer
mmu-miR-5132-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5132-3p mimic mmu-miR-5132-3p mimic

HY-153490D

*FAM labled ISIS 5132* sodium**	Fluorescent Dye	Cancer
FAM labled ISIS 5132 sodiumis a FAM labled ISIS 5132 sodium.

HY-153490E

*Cy3 labled ISIS 5132* sodium**	Fluorescent Dye	Cancer
Cy3 labled ISIS 5132 sodium is a Cy3 labled ISIS 5132 sodium.

HY-153490C

*ISIS 5132* sodium scrambled negative control**	Raf	Cancer
ISIS 5132 sodium scrambled negative control is the sequence scrambled negative control of ISIS 5132 sodium.

HY-RI01877A

*hsa-miR-6132* antagomir**	MicroRNA	Cancer
hsa-miR-6132 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6132 antagomir hsa-miR-6132 antagomir

HY-136175B

cis-Revumenib cis-SNDX-5613	Epigenetic Reader Domain	Cancer
cis-Revumenib (cis-SNDX-5613) is an isomer of Revumenib (HY-136175). Revumenib (SNDX-5613) is a potent and specific Menin-MLL inhibitor with a binding K_i of 0.149 nM and a cell based IC₅₀ of 10-20 nM. Revumenib can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .

HY-RI04508A

*rno-miR-5132-3p antagomir*	MicroRNA	Cancer
rno-miR-5132-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-5132-3p antagomir rno-miR-5132-3p antagomir

HY-R04509A

*rno-miR-5132-5p agomir*	MicroRNA	Cancer
rno-miR-5132-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-5132-5p agomir rno-miR-5132-5p agomir

HY-R04508A

*rno-miR-5132-3p agomir*	MicroRNA	Cancer
rno-miR-5132-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-5132-3p agomir rno-miR-5132-3p agomir

HY-R04508

*rno-miR-5132-3p mimic*	MicroRNA	Cancer
rno-miR-5132-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-5132-3p mimic rno-miR-5132-3p mimic

HY-RI03279A

*mmu-miR-5132-5p antagomir*	MicroRNA	Cancer
mmu-miR-5132-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5132-5p antagomir mmu-miR-5132-5p antagomir

HY-RI03278

*mmu-miR-5132-3p inhibitor*	MicroRNA	Cancer
mmu-miR-5132-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5132-3p inhibitor mmu-miR-5132-3p inhibitor

HY-RI04509A

*rno-miR-5132-5p antagomir*	MicroRNA	Cancer
rno-miR-5132-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-5132-5p antagomir rno-miR-5132-5p antagomir

HY-RI03278A

*mmu-miR-5132-3p antagomir*	MicroRNA	Cancer
mmu-miR-5132-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5132-3p antagomir mmu-miR-5132-3p antagomir

HY-RI04509

*rno-miR-5132-5p inhibitor*	MicroRNA	Cancer
rno-miR-5132-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-5132-5p inhibitor rno-miR-5132-5p inhibitor

HY-R03279A

*mmu-miR-5132-5p agomir*	MicroRNA	Cancer
mmu-miR-5132-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5132-5p agomir mmu-miR-5132-5p agomir

HY-R03278A

*mmu-miR-5132-3p agomir*	MicroRNA	Cancer
mmu-miR-5132-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5132-3p agomir mmu-miR-5132-3p agomir

HY-R04509

*rno-miR-5132-5p mimic*	MicroRNA	Cancer
rno-miR-5132-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-5132-5p mimic rno-miR-5132-5p mimic

Host:	Mouse (4) Rabbit (1)
Reactivity:	Human (5) Bovine (1) Rat (3) Mouse (3) Dog (1) Pig (1)
Application:	IHC-P (4) ICC/IF (5) IP (1) WB (5) ELISA (4)
Isotype:	IgG (1) IgG1 (3)
Conjugation:	Non-conjugated (5)
Clonality:	Monoclonal (5)
Modification:	Unmodified (5)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P86440

	Wilms Tumor Protein Antibody (YA6132)	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Wilms Tumor Protein Antibody (YA6132) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Wilms Tumor Protein.

HY-P85440

	Integrin alpha 6 Antibody (YA5132) ITGA6; Integrin alpha-6; CD49 antigen-like family member F; VLA-6; CD antigen CD49f	WB, ICC/IF	Human, Mouse, Rat, Bovine, Dog, Pig
	Integrin alpha 6 Antibody (YA5132) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Integrin alpha 6.

HY-P85921

	Myelin Basic Protein Antibody (YA5613) GDB; Golli MBP; Golli MBP; myelin basic protein; Hemopoietic MBP; HMBPR; HUGO; MBP; MBP_CAVPO; MBP_HUMAN; MGC99675; MLD; Myelin A1 protein; Myelin A1 Protein, basic; Myelin basic protein; Myelin Deficient; Myelin membrane encephalitogenic protein; OTTHUMP00000163776; OTTHUMP00000174387; OTTHUMP00000174388; SHI; Shiverer; SP	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat
	Myelin Basic Protein Antibody (YA5613) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Myelin Basic Protein.

HY-P85940

	Glypican 3 Antibody (YA5632) DGSX; Glypican proteoglycan 3; Glypican-3 [Precursor]; Gpc3; GPC3_HUMAN; GTR2 2; GTR2-2; Heparan sulphate proteoglycan; Intestinal protein OCI 5; Intestinal protein OCI-5; MXR7; OCI 5; OCI-5; OCI5; SDYS; Secreted glypican-3; SGB; SGBS; SGBS1	IHC-P, WB, ICC/IF, ELISA	Human
	Glypican 3 Antibody (YA5632) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Glypican 3.

HY-P85920

	MUM1 Antibody (YA5612) Interferon regulatory factor 4; IRF 4; IRF-4; Irf4; IRF4_HUMAN; LSIRF; Lymphocyte specific interferon regulatory factor; Lymphocyte specific IRF; Lymphocyte-specific interferon regulatory factor; Multiple myeloma oncogene 1; MUM 1; MUM1; NF EM5; NF-EM5; NFEM5; PU.1 interaction partner; Sfpi1/PU.1 interaction partner; Transcriptional activator PIP	IHC-P, WB, ICC/IF, ELISA	Human
	MUM1 Antibody (YA5612) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MUM1.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-153490

ISIS 5132 CGP 69846A; ISIS 9271		Antisense Oligonucleotides
ISIS 5132 is a 20-base phosphorothioate oligonucleotide that specifically down-regulates c-raf expression.

HY-153490A

*ISIS 5132* sodium** CGP 69846A sodium; ISIS 9271 sodium		Antisense Oligonucleotides
ISIS 5132 sodium is a 20-base phosphorothioate oligonucleotide that specifically down-regulates c-raf expression.

HY-R01877

*hsa-miR-6132* mimic**		MicroRNAs miRNA mimics
hsa-miR-6132 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01877A

*hsa-miR-6132* agomir**		MicroRNAs miRNA agomirs
hsa-miR-6132 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI01877

*hsa-miR-6132* inhibitor**		MicroRNAs miRNA inhibitors
hsa-miR-6132 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03279

*mmu-miR-5132-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-5132-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI04508

*rno-miR-5132-3p inhibitor*		MicroRNAs miRNA inhibitors
rno-miR-5132-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03279

*mmu-miR-5132-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5132-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03278

*mmu-miR-5132-3p mimic*		MicroRNAs miRNA mimics
mmu-miR-5132-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-153490D

*FAM labled ISIS 5132* sodium**		Antisense Oligonucleotides
FAM labled ISIS 5132 sodiumis a FAM labled ISIS 5132 sodium.

HY-153490E

*Cy3 labled ISIS 5132* sodium**		Antisense Oligonucleotides
Cy3 labled ISIS 5132 sodium is a Cy3 labled ISIS 5132 sodium.

HY-153490C

*ISIS 5132* sodium scrambled negative control**		Antisense Oligonucleotides
ISIS 5132 sodium scrambled negative control is the sequence scrambled negative control of ISIS 5132 sodium.

HY-RI01877A

*hsa-miR-6132* antagomir**		MicroRNAs miRNA antagomirs
hsa-miR-6132 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI04508A

*rno-miR-5132-3p antagomir*		MicroRNAs miRNA antagomirs
rno-miR-5132-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04509A

*rno-miR-5132-5p agomir*		MicroRNAs miRNA agomirs
rno-miR-5132-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04508A

*rno-miR-5132-3p agomir*		MicroRNAs miRNA agomirs
rno-miR-5132-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04508

*rno-miR-5132-3p mimic*		MicroRNAs miRNA mimics
rno-miR-5132-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI03279A

*mmu-miR-5132-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5132-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03278

*mmu-miR-5132-3p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5132-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI04509A

*rno-miR-5132-5p antagomir*		MicroRNAs miRNA antagomirs
rno-miR-5132-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03278A

*mmu-miR-5132-3p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5132-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI04509

*rno-miR-5132-5p inhibitor*		MicroRNAs miRNA inhibitors
rno-miR-5132-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03279A

*mmu-miR-5132-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5132-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03278A

*mmu-miR-5132-3p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5132-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04509

*rno-miR-5132-5p mimic*		MicroRNAs miRNA mimics
rno-miR-5132-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation:		* Country or Region:
* Applicant Name:		* Organization Name:
* Department:
* Email Address:		* Product Name:
Cat. No.:		* Requested quantity:
* Phone Number:
MCE Japan Authorized Agent:	ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: